DCOY is trading at $6.87, down 28.4% today as the stock undergoes a sharp reversal following yesterday’s private placement-fueled spike.
- Shares had soared on June 29, 2026, after Decoy Therapeutics announced up to $21 million in funding via a private placement intended to support clinical trials.
- Today’s decline reflects significant profit-taking and a normalization of the share price following the recent rally.